Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIFAROTENE vs TRILACICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRIFAROTENE vs TRILACICLIB: Safety Overview

Metric TRIFAROTENE TRILACICLIB
Total FAERS Reports 112 226
Deaths Reported 2 29
Death Rate 1.8% 12.8%
Hospitalizations 1 96
Average Patient Age 26.3 yrs 62.2 yrs
% Female Patients 84.4% 43.9%
FDA Approval Date Oct 4, 2019 Feb 12, 2021
Manufacturer Galderma Laboratories, L.P. Pharmacosmos Therapeutics Inc.
Route TOPICAL INTRAVENOUS
Marketing Status Prescription Prescription